ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2025
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • 2020-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstracts tagged "macrophages"

  • Abstract Number: LB12 • ACR Convergence 2025

    Randomized, Double-Blind, Placebo-Controlled Phase IIa Trial of an Innovative Intra-Articular Apoptotic Cell Therapy in Knee Osteoarthritis (OA): 3-Month Positive Outcomes and Identification of Responder Population (NCT06233474)

    Philip Conaghan1, Bernt Husøy2, Cecilie Rovsing3, Sidsel L Boll4, Liliana Groppa5, Amir Oron6, Asger Bihlet7, Ali Mobasheri8, Tobias Winkler9, Dror Mevorach10, Einat Galamidi11, Lital Weinfeld-Bergman12, Lior Binder12 and Oren Hershkovitz11, 1University of Leeds, Leeds, United Kingdom, 2Sanos Clinic, Herlev, Denmark, 3Sanos Clinic, Gandrup, Denmark, 4Sanos Clinic, Vejle, Denmark, 5T. Mosneaga Republican Clinical Hospital, Chisinau, Moldova, 6Kaplan MC, Rehovot, Israel, 7NBCD A/S, Soeborg, Denmark, 8University of Oulu, Oulu, Finland, 9Charité - Universitätsmedizin Berlin, Berlin, Germany, 10Hadassah-University Hospital, Jerusalem, Israel, 11Enlivex Therapeutics, Ness Ziona, Israel, 12Enlivex Therapeutics, Nes Ziona, Israel

    Background/Purpose: OA is a prevalent disabling disease growing globally due to aging populations and rising obesity. In primary OA, the effects of joint tissue damage accumulate with age,…
  • Abstract Number: 1844 • ACR Convergence 2025

    Disease-Associated Macrophages Express an Injury-Associated Gene Program and Localize to Distinct Compartments in Proliferative and Mixed Histologic Classes of Lupus Nephritis

    Paul Hoover1, Rollin Leavitt2, Jill Buyon3, Jennifer Anolik4, Jennifer Barnas5, Judith James6, Joel Guthridge6, Michelle Petri7, Betty Diamond8, Soumya Raychaudhuri1, Nir Hacohen9, Anne Davidson10 and Arnon Arazi11, 1Brigham and Women's Hospital, Boston, MA, 2Broad Institute, Boston, MA, 3NYU Grossman School of Medicine, New York, NY, 4University of Rochester Medical Center, Rochester, NY, 5University of Rochester, Rochester, NY, 6Oklahoma Medical Research Foundation, Oklahoma City, OK, 7Johns Hopkins University School of Medicine, Timonium, MD, 8The Feinstein Institutes for Medical Research, Manhasset, NY, 9Broad Institute, Cambridge, MA, 10Feinstein Institutes for Medical Research, Manhasset, NY, 11The Feinstein Institutes for Medical Research, Manhasset

    Background/Purpose: In collaboration with the AMP-RA/SLE network, we identified disease-associated macrophages (D-Macs) in kidney biopsies from 155 patients with active lupus nephritis (LN) and 30…
  • Abstract Number: 0925 • ACR Convergence 2025

    Pathogenic role of SPP1+ macrophages in Rheumatoid Arthritis

    Megan M. Hanlon1, Catherine Manning1, Kevin Wei1, Ursula Fearon2 and Ellen M. Gravallese3, 1Brigham and Women's Hospital at Harvard Medical School, Boston, MA, 2Trinity College Dublin, Dublin, Dublin, Ireland, 3Brigham and Women's Hospital, Harvard Medical School, Chestnut Hill, MA

    Background/Purpose: Synovial tissue macrophages (STMs) represent a mixed population of cells contributing to the pathogenesis of rheumatoid arthritis (RA). We identified an enrichment of Secreted…
  • Abstract Number: 1793 • ACR Convergence 2025

    Sex-associated changes to synovial macrophages in the aging joint

    Matthew Dapas1, Erica De Jong2, Yidan Wang3, Cally Mills3, Samuel Dowling4, Tyler Therron5, Carla Marie Cuda3, Dawn Bowdish6 and Deborah Rachelle Winter7, 1Northwestern University Feinberg School of Medicine, Chicago, IL, 2McMaster Immunology Research Centre, Hamilton, ON, Canada, 3Northwestern University, Chicago, IL, 4Ann & Robert H. Lurie Children's Hospital of Chicago, Chicago, IL, 5Northwestern Feinberg School of Medicine, Chicago, IL, 6McMaster University, Hamilton, ON, Canada, 7Northwestern University, Skokie, IL

    Background/Purpose: Macrophages are found in nearly every tissue of the body where they maintain homeostasis and drive healthy immune response. However, macrophages are dysregulated with…
  • Abstract Number: 0921 • ACR Convergence 2025

    Fibrinogen Co-Modified with Malondialdehyde-Acetaldehyde and Citrulline Promotes Pro-Inflammatory Macrophage Differentiation Through p38 and NF-κB Signaling

    Hannah Johnson1, Wenxian Zhou2, Michael Duryee1, Carlos Hunter1, Geoffrey Thiele1 and Ted Mikuls1, 1University of Nebraska Medical Center, Omaha, NE, 2University of Nebraska Medical Center, Bellevue, NE

    Background/Purpose: Citrulline (CIT) and malondialdehyde-acetaldehyde (MAA) co-adduct native proteins in RA tissues to create a dual pro-inflammatory and pro-fibrotic milieu. Our previous work demonstrated that…
  • Abstract Number: 1787 • ACR Convergence 2025

    Spatial and Quantitative Semiautomated Image Analysis of Synovial Biopsies Studied Using a Novel High-Plex Immunofluorescence Platform

    Estefania Quesada-Masachs1, Luis Peñaranda Bolaño1, Aakriti Arora2, Jessica Murillo-Saich3, Edward Lo4, Tad George4, Daniel Tanoeihusada4, Sara McArdle5 and Monica Guma6, 1University of Miami, Miami, FL, 2University of Miami / Jackson Memorial Hospital, Miami, FL, 3University of California, San Diego, San Diego, CA, 4RareCyte, Seattle, WA, 5La Jolla Institute for Immunology, La Jolla, CA, 6University of California San Diego, San Diego, CA

    Background/Purpose: Although not part of the formal ACR criteria for RA, PsA, or OA, synovial pathology can be a helpful tool in clinical practice. Histopathologic…
  • Abstract Number: 0908 • ACR Convergence 2025

    E-602 (Efgitasialase alfa) Enhances Memory B Cell Depletion and Reduces Profibrotic Macrophages via Desialylation in Autoimmune Disease

    Hrishikesh Mehta1, Vijayashree Mysore1, Chih-Hsing Chou1, Lizhi Cao1, Rui Liu2, Tianrui Fan2, Jijun Yuan2, James Broderick1 and Li Peng1, 1Palleon Pharmaceuticals, Waltham, MA, 2Shanghai Henlius Biotech, Shanghai, China (People's Republic)

    Background/Purpose: Abnormal cell surface glycosylation has been observed in various autoimmune diseases, including systemic lupus erythematosus (SLE) and membranous nephropathy. Among these glycan modifications, sialoglycans…
  • Abstract Number: 1779 • ACR Convergence 2025

    Citrullinated and Malondialdehyde-Acetaldehyde Modified Fibrinogen Activates Macrophages and Induces Inflammatory Responses in Coronary Endothelium

    Wenxian Zhou1, Hannah Johnson2, Michael Duryee2, Engle Sharp2, Carlos Hunter2, Tate Johnson2, Mabruka Alfaidi2, Daniel Anderson3, Kishore Bidasee2, Geoffrey Thiele2 and Ted Mikuls2, 1University of Nebraska Medical Center, Bellevue, NE, 2University of Nebraska Medical Center, Omaha, NE, 30587964, Durham, NC

    Background/Purpose: Endothelial cell (EC) dysfunction is a key driver of cardiovascular (CV) complications in rheumatoid arthritis (RA), yet mechanisms underlying EC dysfunction in RA are…
  • Abstract Number: 0893 • ACR Convergence 2025

    Transcriptomic insights into GCA compared to clinically diverse controls: Inflammation, Aging, Therapeutic Targets and the role of SPP1 in the temporal artery

    Ingrid Lindquist1, Alisha Eskew2, Dongsoek Choi3, David Wilson4, Diva Salomao5, Hillary Stiefel4, Daniel Albert4, Kiana Vakil-Gilani6, Daniela Ghetie7, James Rosenbaum8 and Marcia Friedman9, 1Portland VA Medical Center, Portland, OR, 2OHSU, Portland, OR, 3OHSU, Portland, 4Casey Eye Institute OHSU, Portland, OR, 5Mayo Clinic, Rochester, MN, 6PeaceHealth, Portland, OR, 7OHSU, Lake Oswego, OR, 8Legacy Devers Eye Institute, Portland, OR, 9Immpact Bio, Beaverton, OR

    Background/Purpose: Giant cell arteritis (GCA) is the most common vasculitis in people over 50 years old and is a clinical diagnosis bolstered by non-specific inflammatory…
  • Abstract Number: 1774 • ACR Convergence 2025

    Citrullinated and Malondialdehyde-Acetaldehyde Co-Modified Fibrinogen Activates Macrophages and Induces Pro-Fibrotic shift in Coronary Endothelium Phenotype

    Nozima Aripova1, Wenxian Zhou2, Hannah Johnson1, Michael Duryee1, Kimberley Sinanan1, Carlos Hunter1, Tate Johnson1, Mabruka Alfaidi1, Daniel Anderson3, Kishore Bidasee1, Geoffrey Thiele1 and Ted Mikuls1, 1University of Nebraska Medical Center, Omaha, NE, 2University of Nebraska Medical Center, Bellevue, NE, 30587964, Durham, NC

    Background/Purpose: Rheumatoid arthritis (RA) patients are at increased risk for developing heart failure with preserved ejection fraction (HFpEF), which is characterized by impaired left ventricular…
  • Abstract Number: 0865 • ACR Convergence 2025

    Spatial Transcriptomic Analysis of Calcinosis Cutis in Dermatomyositis Uncovers Disease-Associated Pathways Involving IL-6, Tissue Remodeling, and Osteopontin

    Cassie Parks1, York Wang1, Lisa Christopher-Stine2, Jemima Albayda2, Joel Sunshine3, Shira Ziegler1 and Chris Mecoli1, 1Johns Hopkins University School of Medicine, Baltimore, MD, 2Johns Hopkins University, Baltimore, MD, 3Johns Hopkins University School of Medicine, Baltimore

    Background/Purpose: Calcinosis cutis affects up to 20% of adults with dermatomyositis (DM), causing significant morbidity including recurrent infections, incapacitating pain, and functional impairment. Current management…
  • Abstract Number: 1763 • ACR Convergence 2025

    Spatial Organization and Function of Disease-Associated Macrophages in Lupus Nephritis: Insights from Cross-Species Analyses

    Paul Hoover1, Chirag Raparia2, Rollin Leavitt3, Nir Hacohen4, Arnon Arazi5 and Anne Davidson2, 1Brigham and Women's Hospital, Boston, MA, 2Feinstein Institutes for Medical Research, Manhasset, NY, 3Broad Institute, Boston, MA, 4Broad Institute, Cambridge, MA, 5The Feinstein Institutes for Medical Research, Manhasset

    Background/Purpose: Myeloid cells are linked to kidney injury in lupus nephritis (LN) but lack targeted therapies, underscoring the need to better understand myeloid biology in…
  • Abstract Number: 0812 • ACR Convergence 2025

    Anti-CD206 CAR T Cell Immunotherapy Mitigates Dermal Pathology in Systemic Sclerosis

    Chanhyuk Park1, Helen Jarnagin2, Asmaa Mohamed3, Noelle Kosarek4, Owen Wilkins1, Fred Kolling1, Yina Huang1, Michael Whitfield5 and Patricia Pioli1, 1Geisel School of Medicine at Dartmouth, Lebanon, NH, 2Dartmouth College, Lebanon, NH, 3Geisel School of Medicine at Dartmouth, Charlottesville, VA, 4Dartmouth Geisel School of Medicine, Lebanon, NH, 5Geisel School of Medicine, Lebanon, NH

    Background/Purpose: Systemic sclerosis (SSc) is a progressive, chronic multi-system disorder of unknown etiology that is characterized by immune dysfunction, fibrosis, and loss of dermal white…
  • Abstract Number: 1650 • ACR Convergence 2025

    Malondialdehyde-Acetaldehyde and Citrulline Modified Proteins are Overexpressed in Cardiac Tissues in Rheumatoid Arthritis-Associated Heart Failure and Mediate Endothelial Cell Dysfunction

    Hannah Johnson1, Wenxian Zhou2, Michael Duryee1, Engle Sharp1, Kimberley Sinanan1, Carlos Hunter1, Tate Johnson1, Mabruka Alfaidi1, Daniel Anderson3, Geoffrey Thiele1 and Ted Mikuls1, 1University of Nebraska Medical Center, Omaha, NE, 2University of Nebraska Medical Center, Bellevue, NE, 30587964, Durham, NC

    Background/Purpose: Previous reports show that malondialdehyde-acetaldehyde (MAA) adducts are overexpressed in RA, especially in joint/lung tissues, and that they colocalize with citrulline (CIT). This is…
  • Abstract Number: 0747 • ACR Convergence 2025

    Patterns of Macrophage Polarization Induced by Serum from Patients with Giant Cell Arteritis and Takayasu’s Arteritis

    Irene Carrión-Barberà1, Ryan D. Stultz2, David Cuthbertson3, Nader Khalidi4, Curry Koening5, Carol Langford6, Carol McAlear7, Paul Monach8, Larry Moreland9, Christian Pagnoux10, Philip Seo11, Kenneth Warrington12, Peter Merkel7 and Christian Lood13, 1Department of Rheumatology. Hospital del Mar, Barcelona, Spain, 2University of Washington, Division of Rheumatology, Seattle, WA, 3University of South Florida, Tampa, 4Department of Medicine, McMaster University and St. Joseph’s Healthcare, Hamilton, Canada, 5University of Texas Dell Medical School, Austin, TX, 6Cleveland Clinic, Moreland Hills, OH, 7University of Pennsylvania, Philadelphia, PA, 8VA Boston Healthcare System, Boston, MA, 9University of Colorado, Denver, CO, 10Mount Sinai Hospital, University Health Network, Toronto, and Canadian Vasculitis Research Network (CanVasc), Toronto, ON, Canada, 11Johns Hopkins University, Baltimore, MD, 12Mayo Clinic, ROCHESTER, MN, 13University of Washington, Division of Rheumatology, Seattle

    Background/Purpose: Macrophages play a central role in the pathogenesis of large-vessel vasculitides, including giant cell arteritis (GCA) and Takayasu’s arteritis (TAK). Characterizing patterns of macrophage…
  • 1
  • 2
  • 3
  • …
  • 14
  • Next Page »
Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

Embargo Policy

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM CT on October 25. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology